Acemetacin for Active Axial Spondyloarthritis
Part of Bones, joints & muscles clinical trials.
This study tests whether a pain-relief medication called acemetacin works well and is safe for people with axial spondyloarthritis, a type of inflammatory spine condition. Researchers will track your symptoms and side effects over time in a real-world setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with axial spondyloarthritis (inflammation of the spine and joints) based on specific medical criteria
- Your disease is currently active (measured by a score above 2.1 on the ASDAS scale)
- You have not taken certain steroid medications or biologic treatments in the past 3 months
- You do not have a history of stomach ulcers, bleeding, or inflammatory bowel disease
- You do not have severe heart, kidney, or liver problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called 608 for people with a type of spinal arthritis that doesn't show up on X-rays but causes inflammation and back pain. It's a 3-year study to see if the drug can help control symptoms and improve quality of life.
This study tests a new medicine called 608 for people with non-radiographic axial spondyloarthritis (a type of inflammatory back pain). The goal is to see if it can reduce pain and inflammation.
This study tracks how axial spondyloarthritis progresses over time in Chinese patients. It helps doctors understand the natural course of the disease and improve care.
This trial tests whether taking nonsteroidal anti-inflammatory drugs (NSAIDs) helps people with axial spondyloarthritis stay in remission and avoid future flare-ups. It’s meant to see if NSAIDs can reduce the chance of symptoms returning and keep disease activity low over time.
This trial tests an investigational medication called SCT650C for people with active axial spondyloarthritis. It aims to see if it can reduce pain and inflammation better than current treatments.
This trial tests whether tofacitinib (a pill that reduces inflammation) can help people with early-stage axial spondyloarthritis, a type of arthritis that mainly affects the spine and pelvis. It's for those who have had symptoms for 2 years or less and have active disease with signs of inflammation in MRI or blood tests.
Hear when a new Axial Spondyloarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.